StockData
HYFTNasdaqPharmaceutical PreparationsFiscal year ends April 30

MindWalk Holdings Corp.

Financials through Q3 FY2026, quarter ended Jan 31, 2026Last filing: 20-F on Jul 23, 2026
$1.32+0.01 (+0.76%)

Close on Oct 19, 2026

Share price

−$0.26 (−16.46%)past year

Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings

MindWalk Holdings Corp. grew revenue 95.9% to C$28.08M over the twelve months to Jan 31, 2026. Free cash flow was -C$11.94M.

Revenue
C$28.08M
+95.9% vs. a year earlier
Free cash flow
-C$11.94M
TTM Q3 2026
EPS, diluted
-0.91 CAD
FY2025

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jan 31, 2026

Valuation

Market cap
–
P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–
Free cash flow yield
–

Fundamentals

Revenue
C$28.08M
EPS, diluted
-0.91 CAD
Free cash flow
-C$11.94M
Diluted shares
47M

Valuation needs the share price. It fills in once daily prices are connected and converted from CAD.

Seven years at a glance

Fiscal years 2019 to 2025 and trailing twelve months, CAD

Revenue

C$28.08M+95.9% YoY

Gross profit

C$16.06M+121.6% YoY

EPS, diluted

–

Free cash flow

-C$11.94M
Reported periodTrailing twelve months